&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-07-28, 18:00

Boehringer Ingelheim and Re-Vana Therapeutics Announce Strategic Collaboration to Develop Long-Acting Ophthalmic Therapies
Kristofer Henninger

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-07-07, 18:00

Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-05, 21:52

Boehringer Ingelheim announces plans to advance potential new treatment for Geographic Atrophy, following positive Phase I results
Clarita Gooden

Popular Posts